Results 51 to 60 of about 171,385 (240)

Correlation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography related parameters with the degree of proliferation in lung adenocarcinoma

Scientific Reports
The objective of this study was to evaluate the correlation between positron emission tomography/computed tomography (PET/CT) parameters and the degree of proliferation of lung adenocarcinoma. A retrospective analysis was conducted on 50 patients who had
Jian-gong Shi, Yan Li, Qing-hua Mu, Ji-ming Zhao, Yan-bing Wang   +4 more
doaj   +1 more source

Imaging characteristics of central neurocytomas according to Ki-67 proliferation index

Frontiers in Oncology
PurposeTo evaluate the imaging characteristics of central neurocytoma (CN) with different Ki-67 indices and reveal its biological behavior.Materials and methodsSixty-nine cases of intraventricular CN confirmed by histopathology were collected ...
Yan-li Zhang, Ling Liu, Wei Li, Chao Ran, Yu-qi Luo   +4 more
doaj   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Aging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel, S. Tissera, E. Paul, J. Zalcberg, R. G. Stirling   +4 more
wiley   +1 more source

Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyResearch in context

The Lancet Regional Health. Europe
Summary: Background: Although Ki-67 is a commonly used proliferation marker in breast cancer (BC), its prognostic value after neoadjuvant chemotherapy (NACT) remains unclear.
Maria Angeliki Toli, Xingrong Liu, Davide Massa, Stefania Lando, Caroline Boman, Nikolaos Tsiknakis, Christian Tranchell, Andri Papakonstantinou, Giuseppe Fotia, Claudio Vernieri, Valentina Guarneri, Jonas Bergh, Maria Vittoria Dieci, Louise Eriksson Bergman, Alexios Matikas, Theodoros Foukakis   +15 more
doaj   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Ki-67 expression in pulmonary tumors—reply [PDF]

Translational Lung Cancer Research, 2016
First of all, we would like to congratulate Professor Chirieac for his excellent discussion on proliferation assessment in lung tumors. Taken together, he concludes that assessment of proliferation is important for the prognosis of non-small cell lung cancer (NSCLC), prediction of brain metastases in patients with lung adenocarcinoma, and the diagnosis,
Mark, Kriegsmann, Arne, Warth
openaire   +2 more sources

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

KI-67 IMMUNOHISTOHEMICAL EXPRESSION IN PROSTATIC LESIONS

The Iraqi Journal of Medical Sciences, 2017
Background: The cell proliferation marker, ki-67, is a nuclear and nucleolar protein, which can be detected during all active phases of the cell cycle (G1, S, G2, and mitosis), but absent from cell resting phases.
Inas A. Rasheed, Alaa G. Hussein, Mohanad M. AbdulGhany   +2 more
doaj   +6 more sources

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis

Veterinary Sciences
A cytological grading system for canine mast cell tumors (MCTs) has been developed, but its integration into clinical routine has been hindered due to its diagnostic limitations.
Christina Marouda, Tilemahos Anagnostou, Barbara Brunetti, Ioannis Savvas, Lysimachos G. Papazoglou, Dimitra Psalla   +5 more
doaj   +1 more source

Prognostic Value of Ki 67 Proliferation Antigen in Canine Malignant Mammary Gland Tumours

Brazilian Journal of Veterinary Pathology, 2011
Canine malignant mammary gland tumours were surgically resected from 78 dogs to determine the prognostic value of Ki 67 Proliferation antigen. After post surgical follow up for minimum of 1 year, 48 dogs were still alive, while 21 dogs had died as a ...
Jayachandra C. Kadthur, Suguna Rao, Byregowda M. Sonnahallipura, Dayananda S. Thimmanahalli, Satyanarayana M. Laxmikanth   +4 more
doaj   +1 more source